Hey Stoops.....yep its a tough market out there but I still maintain cost effectiveness is the key to CUX 's success in the future. All the best for the festive season.... Hastenbrucke
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025